SurgePays 10-Q Flags Going Concern Doubt and Nasdaq Delisting Risk
SURG sits 19% above its 52-week low of $0.202.
Summary
SurgePays' 10-Q reveals going concern doubt, Nasdaq delisting risk, and heavy reliance on convertible debt financing, despite a headline Q2 profit driven by a one-time AT&T settlement gain.
Key Events · Earnings and Guidance · SURG
-
Going Concern Doubt
Management states substantial doubt about the Company's ability to continue as a going concern within one year, citing a $21.3 million working capital deficit and only $1.95 million in unrestricted cash.
-
Nasdaq Delisting Risk
Company received notices for failing the $35 million minimum market value and $1.00 minimum bid price requirements, with compliance deadlines of September 14, 2026 and September 21, 2026.
-
Derivative Liabilities
Recognized $1.1 million in derivative liabilities from convertible note features, including $1.17 million in derivative expense and a $0.29 million fair value gain.
-
Subsequent Financing
After quarter-end, issued $1.27 million in new convertible notes, converted $1.59 million of debt into 7.2 million shares, and sold 17.3 million shares via ATM for $5.85 million gross proceeds.
Analysis · SURG · Technology
The quarterly report reveals that management has substantial doubt about SurgePays' ability to continue as a going concern, with only $1.95 million in unrestricted cash against a $21.3 million working capital deficit. Adding to the pressure, the company faces Nasdaq delisting for failing both the minimum market value and minimum bid price requirements, with compliance deadlines in September 2026. These disclosures, combined with the recent AT&T settlement gain that masked an underlying operating loss, fundamentally alter the risk profile for shareholders.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 44.7% of the 302 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.26%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SURG was trading at $0.24 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $0.20 to $3.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.